Publications by authors named "Don Buesching"

Claim this Profile
F
Field testing the ENSEMBLE Minimum Dataset: performance of an instrument to address heterogeneity of treatment effects.
Susan K Brenneman, Wei Shen, Lee Brekke, Rosirene Paczkowski, Tim Bancroft, Don P Buesching

J Comp Eff Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic clinical trials: U.S. payers' views on their value.
Jonathan Ratner, Daniel Mullins, Don P Buesching, Ronald A Cantrell

Am J Manag Care· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of private industry in pragmatic comparative effectiveness trials.
Don P Buesching, Bryan R Luce, Marc L Berger

J Comp Eff Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.
Lauren J Lee, Andrew P Yu, Scott J Johnson, Howard G Birnbaum, Pavel Atanasov, Don P Buesching

Diabetes Res Clin Pract· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
Michael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, Douglas E Faries, Saeed Motabar, Don P Buesching

J Manag Care Pharm· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.
Kathleen Lang, Martin D Marciniak, Douglas Faries, Michael Stokes, Don Buesching

Value Health· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.
Kathleen Lang, Martin D Marciniak, Doug Faries, Michael Stokes, Don Buesching

Lung Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular events and insulin therapy: a retrospective cohort analysis.
Nicole M Engel-Nitz, Sherry Martin, Peter Sun, Don Buesching, Vivian Fonseca

Diabetes Res Clin Pract· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional 7-year follow-up of anxiety in primary care patients.
Shoshana S Colman, Meryl Brod, Lori P Potter, Don P Buesching, Clayton R Rowland

Depress Anxiety· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of adolescent males with attention-deficit hyperactivity disorder.
Tari D Topolski, Todd C Edwards, Donald L Patrick, Patti Varley, Margaret E Way, Don P Buesching

J Atten Disord· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional status and somatization as predictors of medical offset in anxious and depressed patients.
Sheila K Fifer, Don P Buesching, Curtis J Henke, Lori P Potter, Susan D Mathias

Value Health· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis